Ahluwalia, Tarunveer S. http://orcid.org/0000-0002-7464-3354
Eliasen, Anders U.
Sevelsted, Astrid http://orcid.org/0000-0001-7117-2334
Pedersen, Casper-Emil T. http://orcid.org/0000-0003-2540-5373
Stokholm, Jakob http://orcid.org/0000-0003-4989-9769
Chawes, Bo http://orcid.org/0000-0001-6846-6243
Bork-Jensen, Jette
Grarup, Niels http://orcid.org/0000-0001-5526-1070
Pedersen, Oluf http://orcid.org/0000-0002-3321-3972
Hansen, Torben http://orcid.org/0000-0001-8748-3831
Linneberg, Allan http://orcid.org/0000-0002-0994-0184
Sharma, Amitabh
Weiss, Scott T. http://orcid.org/0000-0001-7196-303X
Evans, Michael D. http://orcid.org/0000-0001-7449-3993
Jackson, Daniel J.
Morin, Andreanne http://orcid.org/0000-0002-5535-9518
Krogfelt, Karen A. http://orcid.org/0000-0001-7536-3453
Schjørring, Susanne http://orcid.org/0000-0001-5575-7252
Mortensen, Preben B.
Hougaard, David M. http://orcid.org/0000-0001-5928-3517
Bybjerg-Grauholm, Jonas http://orcid.org/0000-0003-1705-4008
Bækvad-Hansen, Marie
Mors, Ole
Nordentoft, Merete
Børglum, Anders D. http://orcid.org/0000-0001-8627-7219
Werge, Thomas http://orcid.org/0000-0003-1829-0766
Agerbo, Esben http://orcid.org/0000-0002-2849-524X
Gern, James E. http://orcid.org/0000-0002-6667-4708
Lemanske, Robert F. Jr.
Ober, Carole
Pedersen, Anders G. http://orcid.org/0000-0001-9650-8965
Bisgaard, Hans http://orcid.org/0000-0003-4131-7592
Bønnelykke, Klaus http://orcid.org/0000-0003-2003-1018
Article History
Received: 18 July 2019
Accepted: 29 October 2020
First Online: 16 December 2020
Competing interests
: H.B. has consultant arrangements with Chiesi Pharmaceuticals and Boehringer Ingelheim. T.S.A. is a shareholder in Zealand Pharma A/S and Novo Nordisk A/S. The remaining authors declare no competing interests.